Protocol # ATN 164
Status: Pending
Screen2Prevent (S2P): Using Digital Health to Improve HIV Screening and Prevention for Adolescents in the Emergency Department
Purpose
Increasing HIV Testing in Pediatric Emergency Departments
Short Title
Screen2Prevent (S2P)
Target Accrual
ED: 84,000 cSHS: 280
Actual Accrual
Pending
ClinicalTrials.gov Link
Pending
Eligibility
- 14-24 years of age who are patients in participating Emergency Departments
- Able to read and understand English
Protocol # ATN 165
Status: Pending
An innovative mobile delivery and mHealth intervention to optimize PrEP adherence and persistence among young gay, bisexual, and other men who have sex with men
Purpose
Providing PrEP Services Outside Of The Traditional Clinic Setting
Short Title
Linking Youth to PrEP Services (LYPS)
Target Accrual
272
Actual Accrual
Pending
ClinicalTrials.gov Link
Pending
Eligibility
- 13-24 years of age
- Assigned male sex at birth
- Reports having sex with a cisgender male or a transgender or gender diverse partner in the past year
- Meets CDC indications for Pre-Exposure Prophylaxis (PrEP)
- English or Spanish speaking
Protocol # ATN 166
Status: Enrolling
An integrated strategy of PrEP mobile health support and doxycycline PEP for young gay, bisexual, and other men who have sex with men
Purpose
Integrated strategy of PrEP mobile health support and DroxyPEP
Short Title
CHOOSE
Target Accrual
FG: 32 Pilot: 20 RCT: 200
Actual Accrual
FG: 42
ClinicalTrials.gov Link
FG: NA Pilot: N/A RCT: Pending
Focus Groups:
- 13-24 years of age
- Identifies as a cisgender male
- Not currently taking Pre-Exposure Prophylaxis (PrEP) and interested in learning more about PrEP
- Self-reports as having a high likelihood of HIV acquisition, defined as having anal or vaginal sex with a cisgender male or transgender female in the past 6 months
- English or Spanish speaking
Technical
Pilot and Randomized Controlled Trial:
- 13-24 years of age
- Identifies as cisgender male
- Not currently taking PrEP and interested in learning more about PrEP
- Self-reports as having a high likelihood of HIV acquisition, defined as having anal or vaginal sex with a cisgender male or transgender female in the past 6 months
- HIV negative within 28 days of enrollment
- English or Spanish speaking
Protocol # ATN 168
Status: Enrolling
Values and Preferences for a Novel, Systemic, Injectable Multipurpose Product for HIV and Pregnancy Prevention in Individuals Assigned Female at Birth in the United States
Purpose
Values And Preferences For A New Long-Acting Medication For HIV And Pregnancy Prevention
Short Title
HIV and Pregnancy Protection in Youth (HAPPY)
Target Accrual
IDI: 50 Pilot: 15 DCE: 440
Actual Accrual
IDI:45 S2: 15 S3: 77
ClinicalTrials.gov Link
NA
Eligibility
- 15-24 years of age
- Assigned female at birth
Protocol # ATN 170
Status: Enrolling
Hybrid Type 2 Effectiveness-Implementation Trial of Status Neutral, Integrated Behavioral Activation and Risk Reduction Intervention for Stimulant Use Among Sexually Active Young GBMSM
Purpose
Using Culturally Tailored Counselling That Supports Healthy Sexual and Drug Using Practices
Short Title
IMPACT
Target Accrual
360
Actual Accrual
Enrolled: 10
ClinicalTrials.gov Link
Eligibility
- 15-24 years of age at enrollment
- Self-identifies as cisgender boy or man
- Self-report condomless anal sex with another boy/man – receptive or insertive – while using stimulants (1 hour prior to, or during, sex) within the last 3 months
- Able to read and understand English
Protocol # ATN 172
Status: Pending
Developing a Novel, Multipurpose Injectable Product Containing Cabotegravir (CAB) and Levonorgestrel (LNG) for Healthy, HIV-Negative Young Adult Females in the United States (US)
Purpose
Short Title
MPT
Target Accrual
16
Actual Accrual
Pending
ClinicalTrials.gov Link
Pending
Eligibility
- 18-24 years of age
- Healthy, HIV-negative young adult females
Protocol # ATN 173
Status: Pending
Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections Among Adolescent and Young People Who Were Assigned
Female at Birth in the United States
Purpose
Doxycycline post-exposure prophylaxis (DoxyPEP) to reduce sexually transmitted infection (STI) rates for adolescent and young people who were assigned female at birth (AFAB) when compared to standard STI testing, treatment, and sexual health counseling
Short Title
foXXy doxy
Target Accrual
760
Actual Accrual
Pending
ClinicalTrials.gov Link
Eligibility
- 13-29 years of age
- Who were assigned female at birth (AFAB), independent of gender identity
- Self-reported gonorrhea, chlamydia, and/or early syphilis diagnosis in the 12 months prior to screening
- Reports condomless vaginal/front hole and/or anal intercourse at least once in the month prior to screening; and
- Fluent in English (able to read, speak, and understand English).